Skip to main content
Jamie (Fountain) Capal, MD, Child Neurology, Chapel Hill, NC, University of North Carolina Hospitals

JamieKorin(Fountain)CapalMD

Child Neurology Chapel Hill, NC

Neurodevelopmental Disabilities

Associate Professor of Pediatrics and Neurology

Dr. Capal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Capal's full profile

Already have an account?

Summary

  • Dr. Jamie Capal is a Child Neurologist and Neurodevelopmental Disabilities Specialist at UNC Chapel Hill and the Carolina Institute for Developmental Disabilities. Her clinical and research activities focus on neurogenetic conditions that result in neurodevelopmental impairments across the lifespan, such as Tuberous Sclerosis Complex, Neurofibromatosis, and Angelman syndrome.

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Neurodevelopmental Disabilities, 2008 - 2012
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2006 - 2008
  • Albany Medical College
    Albany Medical CollegeClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2020 - 2025
  • OH State Medical License
    OH State Medical License 2006 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2025
  • KY State Medical License
    KY State Medical License 2012 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Neurodevelopmental Disabilities

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells  
    Darcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research

Professional Memberships

Hospital Affiliations